Cationic liposomes as gene delivery system: transfection efficiency and new application.
暂无分享,去创建一个
[1] Rob Lambkin-Williams,et al. Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine. , 2010, Vaccine.
[2] Yvonne Perrie,et al. Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[3] Li Yang,et al. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. , 2010, International journal of pharmaceutics.
[4] Jeong-Sook Park,et al. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. , 2010, International journal of pharmaceutics.
[5] H. Tsukada,et al. T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. , 2010, International journal of pharmaceutics.
[6] Yi-Hui Deng,et al. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes. , 2010, Biomaterials.
[7] Yang Zhang,et al. DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. , 2010, International journal of pharmaceutics.
[8] Andrew D. Miller,et al. DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[9] S. Simões,et al. Physicochemical properties of transferrin-associated lipopolyplexes and their role in biological activity. , 2010, Colloids and surfaces. B, Biointerfaces.
[10] S. Simões,et al. Design of peptide-targeted liposomes containing nucleic acids. , 2010, Biochimica et biophysica acta.
[11] P. Dario,et al. Evaluation of cationic liposomes composed of an amino acid-based lipid for neuronal transfection. , 2010, Nanomedicine : nanotechnology, biology, and medicine.
[12] N. Ali,et al. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[13] W. Radchatawedchakoon,et al. Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery. , 2010, Bioorganic & medicinal chemistry.
[14] A. Noël,et al. Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth. , 2009, Cancer letters.
[15] M. H. Santana,et al. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes. , 2009, Colloids and surfaces. B, Biointerfaces.
[16] M. Brgles,et al. Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response. , 2009, Vaccine.
[17] T. Ishida,et al. Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[18] M. Ramezani,et al. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. , 2009, Colloids and surfaces. B, Biointerfaces.
[19] S. Simões,et al. Cationic liposome-DNA complexes as gene delivery vectors: Development and behaviour towards bone-like cells. , 2009, Acta biomaterialia.
[20] T. Ishida,et al. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[21] K. Cheng,et al. Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[22] R. C.-Gaudreault,et al. Spectroscopic characterization of DMPC/DOTAP cationic liposomes and their interactions with DNA and drugs. , 2009, Chemistry and physics of lipids.
[23] Joseph Rosenecker,et al. Current prospects for mRNA gene delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[24] C. Cametti,et al. Comparison of different commercially available cationic liposome-DNA lipoplexes: Parameters influencing toxicity and transfection efficiency. , 2009, Colloids and surfaces. B, Biointerfaces.
[25] Minhyung Lee,et al. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. , 2008, Biomaterials.
[26] N. Plesnila,et al. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[27] T. Anchordoquy,et al. Cholesterol domains in cationic lipid/DNA complexes improve transfection. , 2008, Biochimica et biophysica acta.
[28] Vinay S. Sharma,et al. Synthetic polymeric vectors in gene therapy , 2008 .
[29] T. Mayumi,et al. In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes. , 2008, Journal of bioscience and bioengineering.
[30] G. De Rosa,et al. Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[31] Qiang Zhang,et al. Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[32] S. Takeoka,et al. Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. , 2008, Bioconjugate chemistry.
[33] Y. Maitani,et al. Hydroxyethylated cationic cholesterol derivatives in liposome vectors promote gene expression in the lung. , 2008, International journal of pharmaceutics.
[34] T. Ishida,et al. Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.
[35] H. Faneca,et al. Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[36] Andrew D. Miller. Towards Safe Nanoparticle Technologies for Nucleic Acid Therapeutics , 2008, Tumori.
[37] K. Braeckmans,et al. A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. , 2008, Journal of controlled release : official journal of the Controlled Release Society.
[38] Lu Li,et al. Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. , 2007, Lung cancer.
[39] Y. Maitani,et al. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. , 2007, International journal of pharmaceutics.
[40] G. Damonte,et al. Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma. , 2007, Mutation research.
[41] K. Braeckmans,et al. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[42] T. Nagai,et al. Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[43] A. Masotti,et al. The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency. , 2006, Colloids and surfaces. B, Biointerfaces.
[44] Z. Sideratou,et al. Factors mediating lipofection potency of a series of cationic phosphonolipids in human cell lines. , 2006, Biochimica et biophysica acta.
[45] K. Braeckmans,et al. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick? , 2006, Biochemistry.
[46] R. Mahato. Water insoluble and soluble lipids for gene delivery. , 2005, Advanced drug delivery reviews.
[47] Y. Barenholz,et al. Nanostructure of cationic lipid-oligonucleotide complexes. , 2004, Biophysical journal.
[48] Martin C Garnett,et al. The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[49] R. Debs,et al. The effect of liposome size on the final lipid/DNA ratio of cationic lipoplexes. , 2004, Biophysical journal.
[50] M. Hope,et al. Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. , 2002, Biochimica et biophysica acta.
[51] Y. Barenholz,et al. Interplay in lipoplexes between type of pDNA promoter and lipid composition determines transfection efficiency of human growth hormone in NIH3T3 cells in culture. , 2001, Biochimica et biophysica acta.
[52] A. Urtti,et al. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[53] Düzgüneş,et al. Mechanisms and kinetics of liposome-cell interactions. , 1999, Advanced drug delivery reviews.
[54] J. Birchall,et al. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes. , 1999, International journal of pharmaceutics.
[55] F. Szoka,et al. Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes , 1999, Gene Therapy.
[56] Simon C Watkins,et al. Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection , 1999, Gene Therapy.
[57] P. Ross,et al. Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.
[58] T Salditt,et al. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.
[59] T. Yotsuyanagi,et al. [Cationic liposomes in gene delivery]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.
[60] O. Zelphati,et al. Analytical methods for the characterization of cationic lipid-nucleic acid complexes. , 1998, Human gene therapy.
[61] T. Anchordoquy,et al. Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. , 1997, Archives of biochemistry and biophysics.
[62] J. Legendre,et al. Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. , 1997, Biochimica et biophysica acta.
[63] Joachim O. Rädler,et al. Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes , 1997, Science.
[64] K. Mechtler,et al. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. , 1996, Human gene therapy.
[65] Xiang Gao,et al. Cationic liposome-mediated gene transfer. , 1995, Gene therapy.
[66] H. Farhood,et al. The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. , 1995, Biochimica et biophysica acta.
[67] I. Verma,et al. Cationic liposome-mediated RNA transfection. , 1993, Methods in enzymology.
[68] J. Northrop,et al. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[69] G. J. Dimitriadis. Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes , 1978, Nature.
[70] G Poste,et al. Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. , 1973, Biochimica et biophysica acta.